GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (HKSE:01513) » Definitions » Cash Flow for Dividends

Livzon Pharmaceutical Group (HKSE:01513) Cash Flow for Dividends : HK$-1,499 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Livzon Pharmaceutical Group Cash Flow for Dividends?

Livzon Pharmaceutical Group's cash flow for dividends for the three months ended in Sep. 2024 was HK$-1,021 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was HK$-1,499 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Livzon Pharmaceutical Group's quarterly payment of dividends increased from Mar. 2024 (HK$-25 Mil) to Jun. 2024 (HK$-399 Mil) and increased from Jun. 2024 (HK$-399 Mil) to Sep. 2024 (HK$-1,021 Mil).

Livzon Pharmaceutical Group's annual payment of dividends declined from Dec. 2021 (HK$-1,540 Mil) to Dec. 2022 (HK$-1,452 Mil) but then increased from Dec. 2022 (HK$-1,452 Mil) to Dec. 2023 (HK$-1,739 Mil).


Livzon Pharmaceutical Group Cash Flow for Dividends Historical Data

The historical data trend for Livzon Pharmaceutical Group's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Cash Flow for Dividends Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -966.38 -1,304.01 -1,539.61 -1,451.65 -1,738.58

Livzon Pharmaceutical Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -969.01 -54.08 -24.76 -398.54 -1,021.37

Livzon Pharmaceutical Group Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-1,499 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Livzon Pharmaceutical Group Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment in PRC which is pharmaceutical manufacturing.
Executives
Zhu Baoguo 2201 Interest of corporation controlled by you

Livzon Pharmaceutical Group Headlines

No Headlines